openPR Logo
Press release

Chronic Spontaneous Urticaria Therapeutics Market Size in the 7MM was ~USD 2,200 Million in 2023, is expected to increase by 2034, and estimates DelveInsight

12-04-2024 07:46 PM CET | Health & Medicine

Press release from: ABNewswire

Chronic Spontaneous Urticaria Therapeutics Market Size in

DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as well as the Chronic Spontaneous Urticaria market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Discover Key Insights into the Chronic Spontaneous Urticaria Market with DelveInsight's In-Depth Report @ Chronic Spontaneous Urticaria Market Size [https://www.delveinsight.com/sample-request/chronic-spontaneous-urticaria-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Chronic Spontaneous Urticaria Market

* In November 2024:- Celldex Therapeutics- The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
* In November 2024:- Escient Pharmaceuticals Inc.- Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria (CALM-CSU). Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urticaria
* In November 2024:- Jemincare- A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled Phase II Clinical Study to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Adult Patients with Chronic Spontaneous Urticaria Inadequately Controlled by H1 Antihistamines
* In November 2024:- Jasper Therapeutics Inc.- A Phase 1B/2A, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Treatment With, Or Who Cannot Tolerate Omalizumab.
* In November 2024:- Novartis Pharmaceuticals- The purpose of this extension study is to collect long-term efficacy, safety and tolerability data on remibrutinib in a selected group of participants with Chronic Spontaneous Urticaria (CSU) who previously completed the treatment phase of remibrutinib preceding Phase 3 studies. This study will also fulfill the Novartis commitment to provide post-trial access to participants who have completed the preceding Phase 3 studies, where applicable.
* According to DelveInsight's epidemiology model, the total diagnosed prevalent cases of chronic spontaneous urticaria were approximately 2.8 million among the 7MM in 2023 which is expected to change during the forecast period (2024-2034).
* In the US, there were approximately 521 thousand diagnosed prevalent cases of chronic spontaneous urticaria in 2023 which was nearly 19% of the total 7MM.
* Among the EU4 and the UK, Germany had the highest diagnosed prevalent cases of chronic spontaneous urticarial in 2023 with approximately 327 thousand cases followed by France with nearly 255 thousand cases. On the other hand, Spain accounted for the least with approximately 163 thousand cases.
* In 2023, Japan accounted for the highest diagnosed prevalent cases of chronic spontaneous urticaria with approximately 1 million cases.
* Among the age-specific diagnosed prevalent cases of chronic spontaneous urticaria in the US, there were approximately 47 thousand, 80 thousand, 72 thousand, 81 thousand, 86 thousand, and 156 thousand cases in the age groups



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Spontaneous Urticaria Therapeutics Market Size in the 7MM was ~USD 2,200 Million in 2023, is expected to increase by 2034, and estimates DelveInsight here

News-ID: 3771983 • Views:

More Releases from ABNewswire

VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feasterville-Trevose
VIP Auto PA: Auto Brokers Near Me Redefine Transparent Car Leasing in Feastervil …
VIP Auto PA continues serving Pennsylvania with transparent, factory-direct car leasing services from its Feasterville-Trevose location, offering zero-down options and no-haggle pricing across all vehicle makes and models. Feasterville-Trevose, PA - The traditional car-buying experience has long frustrated consumers with high-pressure sales tactics and inflated pricing structures. VIP Auto PA [http://www.vipautopa.com/] continues addressing these industry pain points through a customer-centric brokerage model that has served Pennsylvania drivers since 2007. Operating from
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic Wellness Treatments
Austin Nail Salon Dream Spa Expands Service Menu with Apres Gel-X and Holistic W …
Dream Spa in Austin expands with Apres Gel-X nails, infrared sauna, and head spa treatments, offering comprehensive beauty and wellness services at its Airport Boulevard location near downtown Austin. Dream Spa [https://www.dreamspaatx.com/], located at 5301 Airport Blvd, Suite 200 in Austin, Texas, has announced the expansion of its service offerings to include authentic Apres Gel-X nail extensions, infrared sauna therapy, and signature head spa treatments. The locally established business continues to
Terrance Private Investigator Expands Houston Private Investigator Services with Community Support Program
Terrance Private Investigator Expands Houston Private Investigator Services with …
Terrance Private Investigator launches a Houston community program offering consultation, family case support, and professional investigation services to residents facing sensitive personal matters. A Houston-based investigative firm is taking action to support families facing difficult personal situations. Terrance Private Investigator & Associates [https://piterrance.com/] has announced a new community initiative designed to provide accessible resources and confidential case consultations for residents throughout the Houston area. The program addresses growing concerns among families facing
El Monte Agency Strengthens Home Insurance Options and Community Protection Services
El Monte Agency Strengthens Home Insurance Options and Community Protection Serv …
Marvin Martinez: Allstate Insurance strengthens El Monte's insurance options with bilingual services, comprehensive coverage, and community-focused customer education, earning Elite Agent recognition through consistent service excellence. El Monte, California - The local insurance landscape continues to evolve as Marvin Martinez, of Allstate Insurance [https://agents.allstate.com/marvin-martinez-el-monte-ca.html?utm_source=GMB&utm_medium=Website], reinforces the company's commitment to protecting families and businesses throughout the San Gabriel Valley. The agency's focus on personalized coverage solutions has positioned it as a trusted

All 5 Releases


More Releases for Chronic

Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030 This latest report researches the industry structure,
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991 This latest report researches the
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them